• Please log in or register to access this feature.
You have full text access to this OnlineOpen article

Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure

  1. Marwick,
  2. Lauer,
  3. Lobo,
  4. Nally,
  5. Braun

Article first published online: 5 JAN 2002

DOI: 10.1046/j.1365-2796.1998.00354.x

Issue

Journal of Internal Medicine

Journal of Internal Medicine

Volume 244, Issue 2, pages 155–161, August 1998

Additional Information

How to Cite

Marwick, Lauer, Lobo, Nally and Braun (1998), Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. Journal of Internal Medicine, 244: 155–161. doi: 10.1046/j.1365-2796.1998.00354.x

Author Information

  1. From the Departments of Cardiology and Nephrology, Cleveland Clinic Foundation, Cleveland, OH, USA

* MD, PhD Marwick Dr Department of Cardiology, F15, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA (tel: (216) 444 8312; fax: (216) 445 7306; e-mail: marwict@cesmtp.ccf.org).

Publication History

  1. Issue published online: 5 JAN 2002
  2. Article first published online: 5 JAN 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (208K)

References

  • 1
    Vollmer WM, Wahl PW, Blagg CR. Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med 1983; 308: 1553 8.
  • 2
    Braun WE, Philips D, Vidt DG, Novick AC, Nakamoto S, Popowniak KL et al. The course of coronary artery disease in diabetics with and without renal allografts. Transplant Proc 1983; 15: 1114 20.
  • 3
    Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986; 81: 630 4.
  • 4
    Brunner FP, Fassbinder W, Broyer M, Oules R, Brynger H, Rizzoni G et al. Survival on renal replacement therapy: Data from EDTA registry. Nephrol Dialysis Transplantation 1988; 2: 109 22.
  • 5
    Legrain M, Rottembourg J, Bentchikou A, Poignet JL, Issad B, Barthelemy A et al. Dialysis treatment of insulin dependent diabetic patients: Ten years experience. Clin Nephrol 1984; 21: 72 81.
  • 6
    Parfrey PS, Griffiths SM, Harnett JD, Taylor R, King A, Hand J, Barre PE. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischaemic heart disease in dialysis patients. Am J Nephrol 1990; 10: 213 21.
  • 7
    Washer GF, Schroter GP, Starzl TE, Weil R. Causes of death after renal transplantation. JAMA 1983; 250: 49 55.
  • 8
    Manske CL, Wang Y, Rector TS, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998 1004.
  • 9
    Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49: 100 3.
  • 10
    Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and non-diabetic uremic renal allograft candidates using dipyridamole thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989; 64: 1017 21.
  • 11
    Senior R, Basu S, Handler C, Raftery EB, Lahiri A. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients. European Heart J 1996; 17: 289 95.
  • 12
    Marwick TH, Torelli J, Harjai K, Haluska B, Pashkow FJ, Stewart WJ, Thomas JD. Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography. J Am College Cardiol 1995; 26: 1180 6.
  • 13
    Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995; 75: 707 10.
  • 14
    Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985 92.
  • 15
    McNeill AJ, Fioretti PM, El-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41 6.
  • 16
    Braun WE, Philips DF, Vidt DG, Novick AC, Nakamoto S, Popowniak KL et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984; 16: 603 7.
  • 17
    Braun WE & Marwick TH. Coronary artery disease in renal transplant recipients. Cleveland Clinic J Med 1994; 61: 370 85.
  • 18
    Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90: 563 70.
  • 19
    Secknus M & Marwick TH. Evolution of dobutamine echocardiography protocols and indications: Safety and side-effects in 3011 studies over 5 years. J Am College Cardiol 1997; 29: 1234 40.
  • 20
    Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am College Cardiol 1993; 21: 1080 6.
  • 21
    Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1311 18.
  • 22
    Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605 14.
  • 23
    Mairesse GH, Marwick TH, Vanoverschelde JL, Baudhuin T, Wijns W, Melin JA, Detry JM. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am College Cardiol 1994; 24: 920 7.
  • 24
    Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EG et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med 1994; 97: 119 25.
  • 25
    Hertzer NR, Beven EG, Young JR, O'hara PJ, Ruschhaupt WF, Graor RA et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223 33.
  • 26
    Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, El-Said EM et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993; 87: 1506 12.
  • 27
    Poldermans D, Arnese M, Fioretti PM, Salustri A, Thomson IR, Boersma E et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am College Cardiol 1995; 26: 648 53.
  • 28
    Poldermans D, Arnese M, Fioretti PM, Boersma E, Thomson IR, Rambaldi R et al. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation 1997; 95: 53 8.
  • 29
    Ballal RS, Secknus MA, Mehta R, Kapadia S, Lauer MS, Marwick TH. Cardiac outcomes in coronary patients with submaximal dobutamine stress echocardiography. Am J Cardiol 1997; 80: 725 9.
View Full Article (HTML) Get PDF (208K)